313 related articles for article (PubMed ID: 16788933)
1. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre.
Moseley H; Ibbotson S; Woods J; Brancaleon L; Lesar A; Goodman C; Ferguson J
Lasers Surg Med; 2006 Jun; 38(5):403-16. PubMed ID: 16788933
[TBL] [Abstract][Full Text] [Related]
2. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
3. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
4. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
Basset-Seguin N
Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
[TBL] [Abstract][Full Text] [Related]
5. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.
Clark C; Bryden A; Dawe R; Moseley H; Ferguson J; Ibbotson SH
Photodermatol Photoimmunol Photomed; 2003 Jun; 19(3):134-41. PubMed ID: 12914598
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
7. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
8. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.
Lehmann P
Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
Morton CA
J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
[TBL] [Abstract][Full Text] [Related]
10. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
13. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
14. [The wider application of photodynamic therapy in dermatology].
Thissen MR; Kuijpers DI; Neumann HA
Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
[TBL] [Abstract][Full Text] [Related]
15. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.
Morton CA; Szeimies RM; Sidoroff A; Braathen LR
J Eur Acad Dermatol Venereol; 2013 May; 27(5):536-44. PubMed ID: 23181594
[TBL] [Abstract][Full Text] [Related]
16. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.
Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW
Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058
[TBL] [Abstract][Full Text] [Related]
19. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
20. Is the pain of topical photodynamic therapy with methyl aminolevulinate any different from that with 5-aminolaevulinic acid?
Ibbotson SH; Valentine R; Hearn R
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):272-3. PubMed ID: 22971196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
